Novacap Group Completes PCI Synthesis Acquisition
Novacap has completed the acquisition of CDMO PCI Synthesis, located in the Boston-area’s biotech and pharmaceutical hub, The company operates an R&D facility in Devens, MA, and a manufacturing facility in Newburyport, MA. PCI Synthesis becomes a wholly owned subsidiary with access to Novacap’s worldwide resources. Pharmaceutical Processing reported the signing of an acquisition agreement last week. Novacap plans to…
French Company To Expand U.S. Pharma Offering With CDMO Acquisition
Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, has signed an agreement to acquire Boston-based PCI Synthesis, a U.S. pharmaceutical contract development and manufacturing organization (CDMO). Located in Boston’s biotech and pharmaceutical hub, PCI Synthesis offers a range of services, including process research and early stage development as well as commercial production of new chemical entities (NCEs),…